CVS Health price target raised to $74 from $58 at RBC Capital
RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform ...
CyberArk price target raised to $481 from $410 at RBC Capital
RBC Capital raised the firm’s price target on CyberArk (CYBR) to $481 from $410 and keeps an Outperform rating on the shares. The company posted a strong quarter with all metrics and initial 2025 ...
RBC Capital Sticks to Its Buy Rating for Pegasystems (PEGA)
RBC Capital analyst Rishi Jaluria maintained a Buy rating on Pegasystems (PEGA – Research Report) yesterday and set a price target of $115.00.
RBC Capital Sticks to Their Buy Rating for Brookfield Corporation (BN)
In a report released today, Robert Kwan from RBC Capital maintained a Buy rating on Brookfield Corporation (BN – Research Report), with a price ...
European Miners to Report Results Under Cloud of U.S. Tariffs, Global Trade War -- Sector Preview
European miners are scheduled to report fourth-quarter and full-year results over the next four weeks. Gold prices are trading near record highs as investors turn to safe haven assets as economic and ...
State of Alaska Department of Revenue Raises Stake in RBC Bearings Incorporated (NYSE:RBC)
State of Alaska Department of Revenue lifted its position in RBC Bearings Incorporated (NYSE:RBC – Free Report) by 5.8% in ...
Artemis2d
Cat bonds remain vital for risk management as investor appetite holds strong, says RBC
Following a record year for catastrophe bond issuance in 2024, the cat bond market remains strong, and according to analysts ...
Insurancenewsnet.com2d
Brighthouse: annuity success, RBC struggles, as possible sale rumors fly
Brighthouse posted very strong Q4 earnings of $5.88 per share, beating the Zacks Consensus Estimate of $4.44 per share.